Your browser doesn't support javascript.
loading
Thermal and clinical performance of a closed device designed for human oocyte vitrification based on the optimization of the warming rate.
Gallardo, Miguel; Hebles, María; Migueles, Beatriz; Dorado, Mónica; Aguilera, Laura; González, Mercedes; Piqueras, Paloma; Montero, Lorena; Sánchez-Martín, Pascual; Sánchez-Martín, Fernando; Risco, Ramón.
Afiliação
  • Gallardo M; University of Seville, C/ Camino de los Descubrimientos s/n, 41092, Seville, Spain; Ginemed Clínicas, C/ Farmacéutico Murillo Herrera nº 3-5, 41010, Seville, Spain.
  • Hebles M; Ginemed Clínicas, C/ Farmacéutico Murillo Herrera nº 3-5, 41010, Seville, Spain.
  • Migueles B; Ginemed Clínicas, C/ Farmacéutico Murillo Herrera nº 3-5, 41010, Seville, Spain.
  • Dorado M; Ginemed Clínicas, C/ Farmacéutico Murillo Herrera nº 3-5, 41010, Seville, Spain.
  • Aguilera L; Ginemed Clínicas, C/ Farmacéutico Murillo Herrera nº 3-5, 41010, Seville, Spain.
  • González M; Ginemed Clínicas, C/ Farmacéutico Murillo Herrera nº 3-5, 41010, Seville, Spain.
  • Piqueras P; Ginemed Clínicas, C/ Farmacéutico Murillo Herrera nº 3-5, 41010, Seville, Spain.
  • Montero L; Ginemed Clínicas, C/ Farmacéutico Murillo Herrera nº 3-5, 41010, Seville, Spain.
  • Sánchez-Martín P; Ginemed Clínicas, C/ Farmacéutico Murillo Herrera nº 3-5, 41010, Seville, Spain.
  • Sánchez-Martín F; Ginemed Clínicas, C/ Farmacéutico Murillo Herrera nº 3-5, 41010, Seville, Spain.
  • Risco R; University of Seville, C/ Camino de los Descubrimientos s/n, 41092, Seville, Spain; National Accelerator Centre, C/ Thomas Alva Edison 7, 41092, Seville, Spain. Electronic address: risco@us.es.
Cryobiology ; 73(1): 40-6, 2016 08.
Article em En | MEDLINE | ID: mdl-27312427
ABSTRACT
Although it was qualitatively pointed out by Fahy et al. (1984), the key role of the warming rates in non-equillibrium vitrification has only recently been quantitatively established for murine oocytes by Mazur and Seki (2011). In this work we study the performance of a closed vitrification device designed under the new paradigm, for the vitrification of human oocytes. The vitrification carrier consists of a main straw in which a specifically designed capillary is mounted and where the oocytes are loaded by aspiration. It can be hermetically sealed before immersion in liquid nitrogen for vitrification, and it is warmed in a sterile water bath at 37 °C. Measured warming rates achieved with this design were of 600.000 ºC/min for a standard DMEM solution and 200.000 ºC/min with the vitrification solution for human oocytes. A cohort of 143 donor MII sibling human oocytes was split into two groups control (fresh) and vitrified with SafeSpeed device. Similar results were found in both groups survival (97.1%), fertilization after ICSI (74.7% in control vs. 77.3% in vitrified) and good quality embryos at day three (54.3% in control vs. 58.1% in vitrified) were settled as performance indicators. The pregnancy rate was 3/6 (50%) for the control, 2/3 (66%) for vitrified and 4/5 (80%) for mixed transfers.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fertilização in vitro / Criopreservação / Vitrificação Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fertilização in vitro / Criopreservação / Vitrificação Idioma: En Ano de publicação: 2016 Tipo de documento: Article